参考文献/References:
[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.[2]Chen W,Sun K,Zheng R,et al.Cancer incidence and mortality in China, 2014[J].Chin J Cancer Res,2018,301:1-12.[3]Wang S,Pan D,Su M,et al.Moderately high folate level may offset the effects of aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and precancerous lesions[J].Genes Nutr,2020,15(1):18. [4]Schwarzenbach H,Hoon DS,Pantel K.Cell-free nucleic acids as biomarkers in cancer patients[J].Nat Rev Cancer,2011,11(6):426-437.[5]Li X,Zhou F,Jiang C,et al.Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis[J].PLoS One,2014,9(7):e103162.[6]Azad TD,Chaudhuri AA,Fang P,et al.Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer[J].Gastroenterology,2020,158(3):494-505.e6.[7]Duffy MJ,McDermott EW,Crown J.Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA[J].Tumour Biol,2018,40(5):1010428318776169.[8]Ye Q,Ling S,Zheng S,et al.Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA[J].Mol Cancer,2019,18(1):114.[9]Corcoran RB,Chabner BA.Application of Cell-free DNA Analysis to Cancer Treatment[J].N Engl J Med,2018,379(18):1754-1765.[10]van Ginkel JH,Slieker FJB,de Bree R,et al.Cell-free nucleic acids in body fluids as biomarkers for the prediction and early detection of recurrent head and neck cancer: A systematic review of the literature[J].Oral Oncol,2017,75:8-15.[11]Rasmussen L,Christensen IJ,Herzog M,et al.Danish Collaborative Group on Early Detection of Colorectal Cancer. Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer[J].Oncotarget,2017,9(12):10247-10258.[12]Leng S,Zheng J,Jin Y,et al.Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis[J].Clin Chim Acta,2018,477:160-165.[13]Mardis ER.Next-generation DNA sequencing methods[J].Annu Rev Genomics Hum Genet,2008,9:387-402.[14]Rubenstein DR,Solomon J.Target-enriched enzymatic methyl sequencing: Flexible, scalable and inexpensive hybridization capture for quantifying DNA methylation[J].PLoS One,2023,18(3):e0282672.[15]Li JS,Ying JM,Wang XW,et al.Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma[J].Chin J Cancer,2013,32(1):3-11.[16]Saif I,Kasmi Y,Allali K,et al.Prediction of DNA methylation in the promoter of gene suppressor tumor[J].Gene,2018,651:166-173.[17]Health Commission of The People’s Republic of China N.National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)[J].Chin J Cancer Res,2022,34(4):309-334.[18]Hsu PK,Chen HS,Liu CC,et al.Application of the Eighth AJCC TNM Staging System in Patients With Esophageal Squamous Cell Carcinoma[J].Ann Thorac Surg,2018,105(5):1516-1522. [19]Grehl C,Wagner M,Lemnian I,et al.Performance of Mapping Approaches for Whole-Genome Bisulfite Sequencing Data in Crop Plants[J].Front Plant Sci,2020,11:176.[20]Han Y,Zheleznyakova GY,Marincevic-Zuniga Y,et al.Comparison of EM-seq and PBAT methylome library methods for low-input DNA[J].Epigenetics,2022,17(10):1195-1204.[21]Peng Y,Xu Y,Zhang X,et al.A novel protein AXIN1-295aa encoded by circAXIN1 activates the Wnt/β-catenin signaling pathway to promote gastric cancer progression[J].Mol Cancer,2021,20(1):158.[22]Enshoji M,Miyano Y,Yoshida N,et al.Eps15/Pan1p is a master regulator of the late stages of the endocytic pathway[J].J Cell Biol,2022,221(10):e202112138.[23]Wang YH,Chang SC,Ansar M,et al.Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer[J].Biomedicines,2021,9(5):453.[24]Miao G,Guo L,Montell DJ.Border cell polarity and collective migration require the spliceosome component Cactin[J].J Cell Biol,2022,221(7):e202202146.[25]Lou S,Meng F,Yin X,et al.Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses[J].Front Immunol,2021,12:719628.[26]Fang Z,Lin M,Li C,et al.A comprehensive review of the roles of E2F1 in colon cancer[J].Am J Cancer Res,2020,10(3):757-768.
相似文献/References:
[1]王万鹏,张启迪,傅承宏,等.整合转录组学识别食管鳞癌关键基因细胞周期蛋白依赖性激酶抑制因子3[J].医学信息,2021,34(05):68.[doi:10.3969/j.issn.1006-1959.2021.05.020]
WANG Wan-peng,ZHANG Qi-di,FU Cheng-hong,et al.Integrated Transcriptomics to Identify the Key Gene Cyclin-dependent Kinase Inhibitor 3 in Esophageal Squamous Cell Carcinoma[J].Journal of Medical Information,2021,34(06):68.[doi:10.3969/j.issn.1006-1959.2021.05.020]
[2]李 丹,吴伟东,古佳升,等.miR-134对食管鳞状细胞癌细胞增殖、迁移和侵袭的影响及其分子机制[J].医学信息,2023,36(08):59.[doi:10.3969/j.issn.1006-1959.2023.08.012]
LI Dan,WU Wei-dong,GU Jia-sheng,et al.Effects of miR-134 on Proliferation,Migration and Invasion of Esophageal Squamous Cell Carcinoma Cells and its Molecular Mechanism[J].Journal of Medical Information,2023,36(06):59.[doi:10.3969/j.issn.1006-1959.2023.08.012]